期刊文献+

活性污泥去除4种典型药品的研究 被引量:7

Research on the removal of four kinds of typical medicine by activated sludge
下载PDF
导出
摘要 通过实验研究了活性污泥在缺氧及好氧条件下对萘普生、苯扎贝特、布洛芬及罗红霉素的去除行为。结果表明,在采用活性污泥去除萘普生及苯扎贝特的过程中吸附与生物降解共同作用,以生物降解作用为主。活性污泥对4种药品的吸附作用大小依次为罗红霉素>苯扎贝特>萘普生>布洛芬。在缺氧及好氧条件下,活性污泥均能有效地生物降解苯扎贝特和萘普生。罗红霉素对活性污泥的致急性毒性浓度值高于布洛芬。 The removing actions of naproxen,benzafibrate,ibuprofen and roxithromycin by activated sludge under aerobic and anoxic conditions have been studied through experiments. The results show that in the process of using activated sludge for removing naproxen and benzafibrate,adsorption and biodegradation work co-efficiently,whereas mainly biodegradation. The order of adsorption degree for the four kinds of medicine are roxithromycin>bezafibrate>naproxen>ibuprofen. Under aerobic and anoxic conditions ,activated sludge can effectively biodegrade benzafibrate and naproxen. Roxithromycin has higher acute toxicity concentration value for activated sludge than ibuprofen.
出处 《工业水处理》 CAS CSCD 北大核心 2016年第2期63-66,70,共5页 Industrial Water Treatment
关键词 药品 吸附 生物降解 活性污泥 medicine adsorption biodegradation activated sludge
  • 相关文献

参考文献15

  • 1Kleyweqt S, Pileqqi V,Yang P, et al. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in On- tario, Canada:Occurrence and treatment efficiency[J]. Sci. Total En- viron. ,2011,409(8) : 1481-1488.
  • 2Lissemore L, Hao C, Yang P, et al. An exposure assessment for selec- ted pharmaceuticals within a watershed in Southern Ontario [J ], Che- mosphere, 2006,64 ( 5 ) : 717 -729.
  • 3Oaks J L,Gilbert M,Virani M Z,et al. Diclofenac residues as the cause of vulture population decline in Pakistan [J ]. Nature, 2004,427 (6975) : 630-633.
  • 4Coxib and traditional NSALD trialist collaboration. Vascular and up- per gastrointestinal effects of non-steroidal anti-inflammatory drugs : Meta-analyses of individual participant data from randomised tri- als [ J ]. The Lancet, 2013,382 (9894) : 60900-60909.
  • 5Yang X, Flowers R C, Weinberg H S, et al. Occurrence and removalof pharmaceuticals and personal care products (PPCPs) in an advan- ced wastewater reclamation plant [J ]. Water Research,2011,45 ( 16 ) : 5218-5228.
  • 6Sipma J, Osuna B, Collado N, et al. Comparison of removal of phar- maceuticals in MBR and activated sludge systems [J ]. Desalination, 2010,250 ( 2 ) : 653-659.
  • 7Bernhard M, Mtiller J, Knepper T P. Biodegradation of persistent po- lar pollutants in wastewater:Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment [J ]. Water Re- search, 2006,40 ( 18 ) : 3419-3428.
  • 8Verlicchi P, AI Aukidy M,Zambello E. Occurrence of pharmaceutical compounds in urban wastewater:Removal,mass load and environ- mental risk after a secondary treatment-A review[J]. Sci. Total En- viron., 2012,429 : 123-155.
  • 9Clara M, Strenn B, Gans O, et al. Removal of selected pharmaceuti- cals ,fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants [J]. Water Research, 2005,39 ( 19 ) : 4797-4807.
  • 10Gobel A,McArdel! C S,Joss A,et al. Fate of sulfonamides,macro- lides, and tfimethoprim in different wastewater treatment technolo- gies[J ]. Sci. Total Environ. ,2007,372(2/3) :361-371.

同被引文献34

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部